Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.67B |
| 2 |
Snowflake
SNOW
|
+$1.03B |
| 3 |
Shopify
SHOP
|
+$940M |
| 4 |
TJX Companies
TJX
|
+$933M |
| 5 |
TSMC
TSM
|
+$779M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$3.39B |
| 2 |
Alibaba
BABA
|
+$1.33B |
| 3 |
AstraZeneca
AZN
|
+$1.12B |
| 4 |
Mastercard
MA
|
+$968M |
| 5 |
Goldman Sachs
GS
|
+$911M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Consumer Discretionary | 23.94% |
| 3 | Communication Services | 14.59% |
| 4 | Financials | 8.49% |
| 5 | Healthcare | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Clearway Energy Class C
CWEN
$6.7B
| $3.41M | ﹤0.01% |
106,772
-255,409
| -71% | -$7.67M |
|
|
ALXN
477
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.37M | ﹤0.01% |
+21,575
| New | +$2.77M |
|
478
Rush Street Interactive
RSI
$2.88B
| $3.37M | ﹤0.01% |
+155,571
| New | +$2.33M |
|
|
479
Alibaba
BABA
$308B
| $3.36M | ﹤0.01% |
14,447
-4,788,312
| -100% | -$1.33B |
|
480
KLA
KLAC
$259B
| $3.36M | ﹤0.01% |
129,740
-111,370
| -46% | -$2.6M |
|
481
H&R Block
HRB
$5.86B
| $3.15M | ﹤0.01% |
+198,946
| New | +$3.44M |
|
482
Accenture
ACN
$108B
| $3.14M | ﹤0.01% |
12,012
-25,311
| -68% | -$6.07M |
|
483
Generac Holdings
GNRC
$12.5B
| $2.94M | ﹤0.01% |
12,927
-21,573
| -63% | -$4.64M |
|
|
NS
484
DELISTED
NuStar Energy L.P.
NS
| $2.94M | ﹤0.01% |
+203,697
| New | +$2.61M |
|
485
KB Home
KBH
$3.59B
| $2.88M | ﹤0.01% |
86,002
-4,244
| -5% | -$152K |
|
486
908 Devices
MASS
$364M
| $2.85M | ﹤0.01% |
+50,000
| New | +$2.92M |
|
487
Valero Energy
VLO
$85.9B
| $2.85M | ﹤0.01% |
50,337
-39,247
| -44% | -$1.93M |
|
488
Certara
CERT
$1.25B
| $2.6M | ﹤0.01% |
+76,966
| New | +$2.82M |
|
489
Veeva Systems
VEEV
$37.4B
| $2.59M | ﹤0.01% |
9,525
-1,335
| -12% | -$374K |
|
|
SEM
490
DELISTED
Select Medical
SEM
| $2.51M | ﹤0.01% |
168,165
-15,091
| -8% | -$197K |
|
491
iShares MSCI ACWI ETF
ACWI
$33.5B
| $2.5M | ﹤0.01% |
27,555
+16,339
| +146% | +$1.4M |
|
492
National Health Investors
NHI
$3.65B
| $2.44M | ﹤0.01% |
35,205
+19,770
| +128% | +$1.26M |
|
493
Avery Dennison
AVY
$13.4B
| $2.43M | ﹤0.01% |
15,695
+5,711
| +57% | +$826K |
|
494
Home BancShares
HOMB
$6.18B
| $2.43M | ﹤0.01% |
+124,831
| New | +$2.27M |
|
|
TCP
495
DELISTED
TC Pipelines LP
TCP
| $2.4M | ﹤0.01% |
81,425
-3,179
| -4% | -$94.9K |
|
|
BPMC
496
DELISTED
Blueprint Medicines
BPMC
| $2.39M | ﹤0.01% |
+21,341
| New | +$2.25M |
|
497
Artisan Partners
APAM
$3.02B
| $2.38M | ﹤0.01% |
47,382
-3,759
| -7% | -$171K |
|
498
HCA Healthcare
HCA
$89.5B
| $2.32M | ﹤0.01% |
+14,130
| New | +$2.07M |
|
499
EPAM Systems
EPAM
$5.03B
| $2.32M | ﹤0.01% |
6,470
-8,648
| -57% | -$2.89M |
|
500
Axos Financial
AX
$5.68B
| $2.31M | ﹤0.01% |
61,560
+31,713
| +106% | +$1M |
|
Similar funds
Jennison Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Jennison Associates held 734 positions worth $140B, up 13% from $124B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q4 2020 filing shows 114 new, 205 increased, 311 reduced and 95 closed positions. Its largest new stake was Farfetch Limited Class A Ordinary Shares: 13,694,960 shares worth $874M. The largest sale was Tesla, an estimated $3.39B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2020 buy was Farfetch Limited Class A Ordinary Shares: 13,694,960 shares worth $874M.
- Jennison Associates added most to Block Inc in Q4 2020, an estimated $1.67B increase.
- Jennison Associates's biggest Q4 2020 reduction was Tesla, cutting an estimated $3.39B.
- Jennison Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $181M.
- Jennison Associates's ten largest holdings make up 40% of its $140B portfolio in Q4 2020.
- Jennison Associates opened 114 new positions and closed 95 in Q4 2020.
- Jennison Associates's portfolio value rose 13% quarter-over-quarter to $140B.
Based on Jennison Associates's 13F filing for Q4 2020, filed 5 Feb 2021.